Do you want to read an article? Please log in or register.
Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups
Cardiovascular Risk and Diseases
Related content
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Carotid Plaque Score is Associated with 10-year Major Adverse Cardiovascular Events in Low-Intermediate Risk Patients Referred to a General Cardiology Community Clinic
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J Cardiovasc Imaging
Matangi MF, Hétu MF, Armstrong DWJ, Shellenberger J, Brouillard D, Baker J, Johnson A, Grubic N, Willms H, Johri AM
doi: 10.1093/ehjci/jeae153
Cardiovascular Risk and Diseases
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease
Diabetes Obes Metab
Lee DY, Moon JS, Jung I, Chung SM, Park SY, Yu JH, Seo JA, Han KD, Kim NH
doi: 10.1111/dom.16165
Cardiovascular Risk and Diseases
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Cardiovasc Diabetol
Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, Zhang PD, Liu D, Li ZH, He Y, Zhou H, Li Z
doi: 10.1186/s12933-025-02711-x
Cardiovascular Risk and Diseases
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Lancet Diabetes Endocrinol
Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
doi: 10.1016/S2213-8587(24)00362-0
Hypertension
Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy
J Am Heart Assoc
Gunnarsson OS, Pihlsgård M, Handmark M, Sarno G, Gonçalves I, Timpka S
doi: 10.1161/JAHA.124.035448
Heart, Artery and Coronary Diseases
Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromes
Eur J Clin Invest
van der Stouwe JG, Godly K, Kraler S, Godly J, Matter CM, Wenzl FA, von Eckardstein A, Räber L, Mach F, Obeid S, Templin C, Lüscher TF, Niederseer D, SPUM‐ACS investigators
doi: 10.1111/eci.14314
Cardiovascular Risk and DiseasesTherapy and Intervention
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Lancet
Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY, SMART-CHOICE 3 investigators
doi: 10.1016/S0140-6736(25)00449-0
Heart, Artery and Coronary Diseases
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial
Am Heart J
Haff N, Horn DM, Bhatkhande G, Sung M, Colling C, Wood W, Robertson T, Gaposchkin D, Simmons L, Yang J, Yeh J, Crum KL, Hanken KE, Lauffenburger JC, Choudhry NK
doi: 10.1016/j.ahj.2025.02.007
Cardiovascular Risk and Diseases
[The CARE (CArdiovasculaR prEvention) Score - an instrument for recording the quality of care of cardiovascular risk patients in the GP practice]
Praxis (Bern 1994)
Rosemann T, Sudano I, Lüscher TF, Strehle O, Senn O
doi: 10.23785/PRAXIS.2024.05.001